ARTICLE | Company News
LipoNova cancer news
August 4, 2008 7:00 AM UTC
LipoNova filed for insolvency on July 25. The company’s lead product candidate is Reniale, an autologous tumor vaccine in Phase III testing as an adjuvant to treat non-metastatic renal cell carcinoma ...